Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

762 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Development of an exon skipping therapy for X-linked Alport syndrome with truncating variants in COL4A5.
Yamamura T, Horinouchi T, Adachi T, Terakawa M, Takaoka Y, Omachi K, Takasato M, Takaishi K, Shoji T, Onishi Y, Kanazawa Y, Koizumi M, Tomono Y, Sugano A, Shono A, Minamikawa S, Nagano C, Sakakibara N, Ishiko S, Aoto Y, Kamura M, Harita Y, Miura K, Kanda S, Morisada N, Rossanti R, Ye MJ, Nozu Y, Matsuo M, Kai H, Iijima K, Nozu K. Yamamura T, et al. Among authors: kanazawa y. Nat Commun. 2020 Jun 2;11(1):2777. doi: 10.1038/s41467-020-16605-x. Nat Commun. 2020. PMID: 32488001 Free PMC article.
Involvement of calmodulin in neuronal cell death.
Shirasaki Y, Kanazawa Y, Morishima Y, Makino M. Shirasaki Y, et al. Among authors: kanazawa y. Brain Res. 2006 Apr 14;1083(1):189-95. doi: 10.1016/j.brainres.2006.01.123. Epub 2006 Mar 20. Brain Res. 2006. PMID: 16545345
The Components of Lumbar Motor Control Are Not Inter-related.
Miyachi R, Nagamori Y, Kanazawa Y, Yamazaki T. Miyachi R, et al. Among authors: kanazawa y. J Musculoskelet Neuronal Interact. 2024 Jun 1;24(2):139-147. J Musculoskelet Neuronal Interact. 2024. PMID: 38825996 Free PMC article.
Lysosomal degradation of PD-L1 is associated with immune-related adverse events during anti-PD-L1 immunotherapy in NSCLC patients.
Kashiwada T, Takano R, Ando F, Kuroda S, Miyabe Y, Owada R, Miyanaga A, Asatsuma-Okumura T, Hashiguchi M, Kanazawa Y, Yoshida H, Seike M, Gemma A, Iwai Y. Kashiwada T, et al. Among authors: kanazawa y. Front Pharmacol. 2024 May 10;15:1384733. doi: 10.3389/fphar.2024.1384733. eCollection 2024. Front Pharmacol. 2024. PMID: 38799168 Free PMC article.
762 results